New Treatments for Memory Loss & Alzheimer’s disease
Finding a cure for Alzheimer’s disease
Led by Dr Emer MacSweeney, an international expert in the field of Alzheimer’s research, we are passionate about finding a cure for Alzheimer’s disease. Our team of cognitive specialists offer trailblazing volunteers the opportunity to access new drugs designed to prevent the progression of memory impairment. Read the FAQ section at the bottom of this page to discover more about volunteering for a clinical trial.
Click on the button below, or call 0800 802 1030 to sign-up
One Clinical Trial, One Life-Changing Opportunity
Because the death of brain cells in Alzheimer’s is currently unstoppable, the only medications available to be prescribed are ‘symptomatic’. These medications manage only the symptoms of dementia, as opposed to delaying its progression.
Symptomatic drugs work to help the dying brain cells function better but, as the disease progresses, more and more brain cells die, leading to a greater decline in cognitive functioning.
Dr Emer MacSweeney, Medical Director of Re:Cognition Health talks clinical trials with Primal Cure
New Alzheimer’s disease treatments
The fight against Alzheimer’s disease is spearheaded by international clinical trials that provide hope through early access to ‘disease-modifying’ Alzheimer’s treatments.
These drugs aim to keep the brain cells alive in order to reduce the progression of memory impairment. There are lots of studies open across the world investigating the effectiveness of new medications. To find out which study might be right for you, or somebody you know, speak to a specialist today
Disease-modifying treatments work to reduce the levels of B amyloid & Tau Protein in the brain and to alter genetic and inflammatory markers. They are believed to be much more effective than the current medications and are available as part of the clinical trials at our clinics.
An individual contribution with a phenomenal global impact
Without inspirational people taking part in Alzheimer’s, dementia and memory loss trials, new medications cannot be licensed for global use. This is because the sponsor needs to demonstrate the efficacy and safety of the medication. Even paracetamol went through a clinical trial at one stage!
We don’t run phase 1 trials at our clinics and the study medication has been given to humans in previous studies.
Potential benefits of joining a clinical trial
- Study volunteers get early access to new treatments for memory loss and are monitored closely throughout the trial
- Outstanding medical care is provided at no cost, including comprehensive health screens, MRI scans and PET scans
- The chance to avoid lengthy NHS waiting lists and access specialist private healthcare
- Travel expenses are reimbursed for each visit and complimentary refreshments are available
- Volunteers have the opportunity to help develop dementia syndrome and memory loss treatments for future generations